Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2018-05-01
סדרה:Experimental Hematology & Oncology
נושאים:
Non-small cell lung cancer
Immune checkpoint inhibitor
Nivolumab
Pericardial effusion
Corticosteroids
גישה מקוונת:http://link.springer.com/article/10.1186/s40164-018-0104-y
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים